Beyond Gavi: Demand-Generated Evidence for Vaccine Sustainability in Africa

Virtual (Zoom webinar)
Network of Impact Evaluation Researchers in Africa (NIERA)
As Kenya takes on greater domestic responsibility for immunization financing, with continued partnership during its Gavi transition, how can locally generated evidence protect coverage, equity and value for money?
This virtual policy webinar, hosted by the University of Michigan Center for Global Health Equity and the Network of Impact Evaluation Researchers in Africa (NIERA), centers on NIERA's evaluation of Kenya's shift from 10-dose to 5-dose measles-rubella vaccine vials. Speakers will look at how immunization programs weigh wastage, product price, total delivery costs, supply-chain realities, missed opportunities and equitable access.
NIERA Chairperson Amos Njuguna will open by explaining how the study grew out of a real policy decision. Apollo Maima, the study's principal investigator, will then present the findings. A panel moderated by University of Michigan faculty will bring together Kenyan government, clinical, health systems, health economics, research, UNICEF and WHO regional perspectives. Together they will discuss what the evidence shows, what remains uncertain and which practical steps could turn promising findings into financially sustainable, equitable action.
